Improve Transparency and Accountability in Health Sector under Building Integrity Blocks for Effective Change (BIBEC) Project

Chapter: Bangladesh | Project range: Local | Year: 2014

Chapter details

About the chapter:
Transparency International Bangladesh (TI-B) is an independent, non-government, non-partisan and non-profit organization with a vision of Bangladesh in which government, politics, business, civil society and the daily lives of the people shall be free from corruption.

CPI Score: 26

CPI Rank: 149

View chapter Profile


Access to medicines, vaccines and other products

Governance & leadership





Theory of Change

Policy & Insititutional Change
Policy Adoption & Amendment Better Institutional Processes


Transparency International Bangladesh's work on health issues mainly includes research and advocacy at local and national levels. The main objective of these activities is to bring about positive changes in policies and practices of concerned authorities in regard to ensuring good governance and integrity in health services.


Transparency International Bangladesh works through research, advocacy and mobilisation of civil society, media and youth groups. A short presentation and policy brief are used in advocacy meeting alongside the full study reports, executive summary, and full presentation of released research reports are sent to respective authorities. The key government authorities are Directorate General of Health Services (DGHS) and Directorate General of Drug Administration (DGDA) under the Ministry of Health and Family Welfare.


  1. Publication of information sheets & policy briefs.
    AdvocacyAwareness raising
  2. Satellite Advice and Information (AI) desks.
  3. Advocacy meetings with health authority.
  4. Face the public sessions (FtP).
  5. Local and national level research on levels of corruption.
    Research & analysis


  1. Drug manufacturing licenses of 11 pharmaceutical companies were cancelled due to failure in following WHO prescribed good manufacturing practices, considering the side effect and potential health hazards in human body, the DGDA banned the registration of 51 medicines and the production of harmful drugs and medicines. DGDA Inspectors visited 5,838 drug stores and 140 pharmaceutical companies and seized medicines that were banned and expired.
  2. Instructed by health ministry, display and written instructions of service-related information were placed in different places for preventing brokers from misleading uneducated patients and e-tendering activities introduced for government purchases.
  3. The National Drug Policy 2016 was formulated. The Policy provides the guidelines for ensuring safe, effective and quality drugs as well as their safe and logical uses. The Drug Act, 2017 (unification of two previous laws namely the Drug Act, 1940 and the Drug Control Ordinance, 1982 and 2006) was drafted. The draft Act provides guidelines for controlling quality, production, import, export, distribution and sale of essential drugs.
  4. The Formalin Control Act, 2015 was enacted to control the harmful use of formalin in foods. In order to reinforce the Food Safety Act, 2013, four regulations were enacted in 2017, which are the Food Safety (Contaminants, Toxins and Harmful Residues) Regulations, 2017, the Food Safety (Labeling) Regulations, 2017, the Use of Food Additives Regulations, 2017 and the Food Sample Collection, Testing and Analysis Regulations, 2017. The Food Safety (Technical Committee) Rules, 2017 was enacted. Bangladesh Food Safety Authority was established in 2015 in light of the Food Safety Act, 2013.
  5. Registration and renewal fees of private health care providing institutions were fixed according to the types of the institutions. Moreover, a committee headed by Additional Secretary (Hospital) of Health Ministry was formed as directed by the Minister for Health to improve the diagnosis service and to fix up the cost of this service.